Shanghai Junshi Biosciences (HKG:1877, SHA:688180) granted 715,000 A-share options to 16 participants under its 2025 A-Share Option Incentive Scheme, according to a Wednesday filing with the Hong Kong bourse.
The options are exercisable into the same number of A-shares at 46.67 yuan apiece, with vesting periods of 12 or 24 months.
Separately, 205 participants are eligible to exercise 11.5 million A-share options in the first exercise period.
The company also plans to cancel 1.7 million A-share options following employee resignations and individual performance assessments.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments